Zomedica Pharmaceuticals (ZOM) Reaches New 12-Month Low at $0.39

Zomedica Pharmaceuticals Corp (CVE:ZOM)’s share price reached a new 52-week low during trading on Friday . The stock traded as low as C$0.39 and last traded at C$0.39, with a volume of 22500 shares. The stock had previously closed at C$0.43.

The stock has a market capitalization of $46.43 million and a P/E ratio of -1.52.

Zomedica Pharmaceuticals (CVE:ZOM) last released its quarterly earnings results on Tuesday, February 26th. The company reported C($0.12) EPS for the quarter.

WARNING: This report was originally posted by Dakota Financial News and is owned by of Dakota Financial News. If you are reading this report on another domain, it was illegally copied and republished in violation of United States & international trademark and copyright law. The original version of this report can be viewed at https://dakotafinancialnews.com/2019/05/17/zomedica-pharmaceuticals-zom-reaches-new-12-month-low-at-0-39.html.

About Zomedica Pharmaceuticals (CVE:ZOM)

Zomedica Pharmaceuticals Corp., a development stage veterinary diagnostic and pharmaceutical company, engages in the discovery, development, and commercialization of pharmaceuticals for the companion pet. Its lead drug product candidate is ZM-007, an oral suspension formulation of metronidazole for the treatment of acute diarrhea in small dog breeds and puppies.

Featured Article: What is Considered a Good Return on Equity (ROE)?

Receive News & Ratings for Zomedica Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zomedica Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.